Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922958 · ClinicalTrials.gov registry record
Immunoparalysis in Acute Kidney Injury After Cardiac Surgery
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 60
- Enrollment target
NCT03922958 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 60 participants.
The verdict
NCT03922958 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Infection and sepsis are common after acute kidney injury (AKI) and increase mortality. In this study, the investigators will determine whether patients with acute kidney injury after cardiac surgery have immunosuppression as judged by blood markers of immunoparalysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2022-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03922958
The ClinicalTrials.gov registry entry for NCT03922958 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03922958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03922958 about?
NCT03922958 is a clinical study titled "Immunoparalysis in Acute Kidney Injury After Cardiac Surgery". Infection and sepsis are common after acute kidney injury (AKI) and increase mortality. In this study, the investigators will determine whether patients with acute kidney injury after cardiac surgery have immunosuppression as judged by blood markers of immunoparalysis.
What is the current status of trial NCT03922958?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2019-02-22. Estimated completion is 2022-05-30.
Who is sponsoring clinical trial NCT03922958?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.